REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Sebre-Med Kft. (Hungary)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: SEBRE-MED Kereskedelmi Kft. Profile Updated: August 16, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Hungarian Download a sample report

Sebre-Med Kft. is based in Hungary. The head office is in Torony. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on October 19, 2005. It currently has a total number of 5 (2023) employees. From the latest financial highlights, Sebre-Med Kft. reported a net sales revenue increase of 1.85% in 2022. Its’ total assets recorded a growth of 22.51%. In 2022, Sebre-Med Kft.’s net profit margin increased by 4.37%.

Headquarters
Kossuth Lajos utca 341/1 hrsz.
Torony; Vas; Postal Code: 9791

Contact Details: Purchase the Sebre-Med Kft. report to view the information.

Basic Information
Total Employees:
Purchase the Sebre-Med Kft. report to view the information.
Outstanding Shares:
Purchase the Sebre-Med Kft. report to view the information.
Registered Capital:
Purchase the Sebre-Med Kft. report to view the information.
Financial Auditors:
Purchase the Sebre-Med Kft. report to view the information.
Incorporation Date:
October 19, 2005
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Sebre-Med Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
1.85%▲
Total operating revenue
18.27%▲
Operating profit (EBIT)
28.11%▲
EBITDA
26.67%▲
Net Profit (Loss) for the Period
20.98%▲
Total assets
22.51%▲
Total equity
3.68%▲
Operating Profit Margin (ROS)
6.65%▲
Net Profit Margin
4.37%▲
Return on Equity (ROE)
3.74%▲
Quick Ratio
-1.27%▼
Cash Ratio
0.62%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo